Actively Recruiting
Evaluating Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation Using the CVAC System Compared to Other Treatments for Kidney Stones in a Prospective Observational Trial
Led by Calyxo, Inc. · Updated on 2026-11-02
1000
Participants Needed
10
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the Steerable Ureteroscopic Renal Evacuation SURE using the CVAC System compared to other common treatments for kidney stones. This prospective, observational trial involves up to 250 participants across approximately 25 sites, focusing on patients undergoing procedures for renal stones such as ureteroscopy or percutaneous nephrolithotomy. The study aims to understand how well these different techniques clear kidney stones and assess their safety. Participants will receive one of several kidney stone removal interventions, including the CVAC System, Flexible and Navigational Ureteral Access Sheath FANS, Direct In-Scope Suction DISS, standard ureteroscopy without suction, or percutaneous nephrolithotomy PCNL. These procedures involve various methods such as laser fragmentation, suction-assisted stone removal, and surgical extraction under anesthesia. Each technique uses specialized devices or methods to visualize and remove kidney stones during treatment. Throughout the study, participants will be monitored and evaluated with follow-up visits to assess outcomes such as residual stone volume 30 days after treatment. Researchers will collect data on stone clearance effectiveness and any safety concerns. Participants will be expected to attend all follow-up procedures and respond to study assessments, with the trial lasting until the study completion date in late 2029.
CONDITIONS
Brief Title
Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here